• 1417 Citations
  • 19 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Z. Kaló is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Biomedical Technology Assessment Medicine & Life Sciences
Cost-Benefit Analysis Medicine & Life Sciences
Hungary Medicine & Life Sciences
Costs and Cost Analysis Medicine & Life Sciences
Decision Support Techniques Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Delivery of Health Care Medicine & Life Sciences
Economics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 1417 Citations
  • 19 h-Index
  • 95 Article
  • 6 Review article
  • 1 Editorial
  • 1 Short survey
1 Citation (Scopus)

Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology

Löblová, O., Csanádi, M., Ozierański, P., Kaló, Z., King, L. & McKee, M., Jan 1 2019, In : Health Policy.

Research output: Contribution to journalArticle

Pharmaceutical Preparations
Biomedical Technology Assessment
Financial Management
2 Citations (Scopus)

Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low-and middle-income countries

Németh, B., Molnár, A., Bozóki, S., Wijaya, K., Inotai, A., Campbell, J. D. & Kaló, Z., Mar 1 2019, In : Journal of Comparative Effectiveness Research. 8, 4, p. 195-204 10 p.

Research output: Contribution to journalReview article

Open Access
Decision Support Techniques
Delivery of Health Care
Decision Making
2 Citations (Scopus)

Cost-utility analysis of cariprazine compared to risperidone among patients with negative symptoms of schizophrenia

Németh, B., Bendes, R., Nagy, B., Götze, Á., Kóczián, K., Horváth, M., Deák, I., Tóth, B. & Kaló, Z., Jan 1 2019, In : Health Policy and Technology.

Research output: Contribution to journalArticle

Cost-Benefit Analysis
Cost effectiveness
Quality-Adjusted Life Years